Aeon Global Health Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2019, Aeon Global Health's inventory turnover ratio sequentially decreased to 8.73 in the third quarter 2019, unsurprisingly, as the Aeon Global Health markets continue to deteriorate, and ADAT's faces growing challenges to bring down its inventories. Aeon Global Health's average inventory processing period in the Mar 31 2019 quarter, has increased to 42 days, from 31 days, in the Dec 31 2017 quarter.

Within Healthcare sector 57 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form in the second quarter 2018, to 632.

ADAT Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Aeon Global Health Corp. Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ADAT Inventory Turnover Ratio	(Mar 31 2019) III. Quarter	(Dec 31 2017) II. Quarter	(Sep 30 2017) I. Quarter	(Jun 30 2017) IV. Quarter	(Dec 31 2016) II. Quarter
Y / Y Inventory Growth	632.19 %	371.05 %	11.75 %	8.75 %	-97.89 %
Y / Y Cost of Sales Growth	1.18 %	-23.86 %	-67.48 %	-84.05 %	19.77 %
Inventory Turnover Ratio (TTM)	8.73	11.79	17.27	29.29	39.72
ADAT's Total Ranking	# 632	#	#	#	#
Average inventory processing period	42	31	21	12	9
Seq. Inventory Growth	23.06 %	5.29 %	8.59 %	420.43 %	-20.83 %
Seq. Cost of Sales Growth	28.47 %	-21.27 %	212.05 %	-67.94 %	-3.32 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 2
Healthcare Sector	# 58
Overall Market	# 632

Inventory Turnover Ratio Statistics
High	Average	Low
39.72	19.14	8.02
(Dec 31 2016)		(Sep 30 2016)

ADAT Company Profile >> Back to ADAT Efficiency Comparisons >> Compare ADAT Inventory Turnover Ratio to its Competitors

Financial Statements
Aeon Global Health's Inventories	$ 0 Millions	Visit ADAT's Balance sheet
Aeon Global Health's Cost of Revenues TTM	$ 4 Millions	Visit ADAT's Income Statement
What are ADAT's Sales?		Visit ADAT's Sales by Segment

Other Inventory Turnover Ratios
Aeon Global Health's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ADAT's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ADAT's Competitors
Inventory Turnover Ratio for ADAT's Suppliers
Inventory Turnover Ratio for ADAT's Customers

You may also want to know
ADAT's Sales Growth Rates	ADAT's Pe Price to earnings ratio	ADAT's Receivables Turnover Ratio	ADAT's Stock Quote
ADAT's Net Income Growth Rates	ADAT's Ps Price to Sales ratio	ADAT's Sales per Employee	ADAT's Asset Turnover Ratio
ADAT's Net Margin	ADAT's Pb Price to Book ratio	ADAT's Financial Strength Ratios	ADAT's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2019, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2019	Inventories at quarter ending Mar 31 2019
Nanomix Corp	19.77	$ 0.068 Millions	$ 0 Millions
Biocryst Pharmaceuticals Inc	18.65	$ 15.347 Millions	$ 1 Millions
Heartbeam Inc	18.52	$ 151.739 Millions	$ 8 Millions
Option Care Health Inc	18.47	$ 473.621 Millions	$ 26 Millions
Irhythm Holdings Inc	18.42	$ 41.698 Millions	$ 2 Millions
Biocept Inc	17.90	$ 10.216 Millions	$ 1 Millions
Medifocus Inc.	17.60	$ 1.931 Millions	$ 0 Millions
Clearday Inc	17.43	$ 2.493 Millions	$ 0 Millions
Collegium Pharmaceutical Inc	16.45	$ 171.735 Millions	$ 10 Millions
Vaso Corporation	15.48	$ 32.578 Millions	$ 2 Millions
Opko Health Inc	15.29	$ 676.557 Millions	$ 44 Millions
Incyte Corporation	15.19	$ 98.605 Millions	$ 6 Millions
Precipio inc	15.18	$ 2.626 Millions	$ 0 Millions
Star Equity Holdings Inc	14.93	$ 84.982 Millions	$ 6 Millions
Rockwell Medical inc	14.84	$ 63.853 Millions	$ 4 Millions
Fonar Corporation	14.61	$ 23.916 Millions	$ 2 Millions
Fortress Biotech Inc	14.40	$ 8.208 Millions	$ 1 Millions
Puma Biotechnology Inc	13.71	$ 36.223 Millions	$ 3 Millions
Natera Inc	12.37	$ 160.631 Millions	$ 13 Millions
Adynxx, Inc.	11.56	$ 1.540 Millions	$ 0 Millions
Infusystem Holdings Inc	10.34	$ 22.705 Millions	$ 2 Millions
Align Technology inc	10.10	$ 555.984 Millions	$ 55 Millions
Veracyte Inc	9.86	$ 33.724 Millions	$ 3 Millions
Igc Pharma Inc	9.80	$ 4.984 Millions	$ 1 Millions
Charles River Laboratories International inc	9.65	$ 1,223.363 Millions	$ 127 Millions
Motus Gi Holdings Inc	9.33	$ 0.618 Millions	$ 0 Millions
Aclaris Therapeutics Inc	9.32	$ 8.660 Millions	$ 1 Millions
Vericel Corporation	8.85	$ 33.134 Millions	$ 4 Millions
Advanced Container Technologies Inc	8.83	$ 1.608 Millions	$ 0 Millions
Hanger inc.	8.76	$ 606.268 Millions	$ 69 Millions

Date modified: 2026-09-08T15:22:04+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.